Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,580,860
-
Total 13F shares
-
9,915,204
-
Share change
-
+223,441
-
Total reported value
-
$308,950,062
-
Put/Call ratio
-
37%
-
Price per share
-
$31.16
-
Number of holders
-
81
-
Value change
-
+$7,619,485
-
Number of buys
-
51
-
Number of sells
-
26
Institutional Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q4 2020
As of 31 Dec 2020,
OptimizeRx Corp - Common Stock (OPRX) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,915,204 shares.
The largest 10 holders included
BlackRock Inc., BLAIR WILLIAM & CO/IL, AVENIR CORP, AWM Investment Company, Inc., First Light Asset Management, LLC, G2 Investment Partners Management LLC, VANGUARD GROUP INC, Handelsbanken Fonder AB, JACOB ASSET MANAGEMENT OF NEW YORK LLC, and WASATCH ADVISORS INC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.